The feasibility and tolerability of newer chemotherapy regimens in the adjuvant setting in older patients with breast cancer.

被引：0
|
作者：
Ladwa, Rahul
Sanmugarajah, Jasotha
机构：
[1] Gold Coast Univ Hosp, Gold Coast, Australia
[2] Gold Coast Univ Hosp, Southport, Qld, Australia
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2015年 / 33卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e12019
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Tolerability of adjuvant chemotherapy (TS-1 versus XELOX) in older patients with gastric cancer
    Park, Jae Ho
    Moon, Hee Seok
    Yun, Gee Young
    Kim, Joo Seok
    Kang, Sun Hyung
    Sung, Jae Kyu
    Jeong, Hyun Yong
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2017, 32 : 81 - 81
  • [42] Adjuvant Chemotherapy in Older Women With Early Breast Cancer
    Trapani, Dario
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (09) : 1652 - +
  • [43] Adjuvant Chemotherapy for Older Patients With Breast Cancer: When Is the Pain Worth the Gain?
    Freedman, Rachel A.
    Winer, Eric P.
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2020, 112 (06): : 551 - 552
  • [44] Impact of adjuvant chemotherapy on clinical and biological ageing in older breast cancer patients
    Brouwers, Barbara
    Hatse, Sigrid
    Dal Lago, Lissandra
    Neven, Patrick
    Vuylsteke, Peter
    Debrock, Guy
    Van den Bulck, Heidi
    Smeets, Ann
    Bechter, Oliver
    Swerts, Evalien
    Bailur, Jithendra Kini
    Kenis, Cindy
    Laenen, Annouschka
    Dalmasso, Bruna
    Schoffski, Patrick
    Pawelec, Graham
    Wildiers, Hans
    CANCER RESEARCH, 2015, 75
  • [45] Feasibility and Tolerability of Adjuvant Capecitabine-Based Chemoradiation in Patients With Breast Cancer and Residual Disease After Neoadjuvant Chemotherapy A Clinical Trial
    Balbach, Meridith L.
    Sherry, Alexander D.
    Rexer, Brent N.
    Abramson, Vandana G.
    Niermann, Kenneth J.
    Johnson, Corbin R.
    Park, Ben Ho
    Mayer, Ingrid A.
    Chakravarthy, A. Bapsi
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 118 (05): : 1262 - 1270
  • [46] Utilization of pegfilgrastim in adjuvant chemotherapy regimens for breast cancer in the community.
    Patt, D. A.
    Espirito, J. L.
    Turnwald, B.
    Hoverman, J. R.
    Neubauer, M. A.
    Busby, L. T.
    Broolos, B. D.
    Kolodziej, M. A.
    Anderson, R. W.
    Beveridge, R. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (27)
  • [47] Breast Cancer Survivorship Care Variations Between Adjuvant Chemotherapy Regimens
    Leal, Alexis D.
    Van Houten, Hay
    Sangaralingham, Lindsey
    Freedman, Rachel A.
    Jemal, Ahmedin
    Neuman, Heather B.
    Haddad, Tufia C.
    Mutter, Robert W.
    Keegan, Theresa H. M.
    Mougalian, Sarah S.
    Loprinzi, Charles L.
    Gross, Cary P.
    Shah, Nilay
    Ruddy, Kathryn J.
    CLINICAL BREAST CANCER, 2018, 18 (04) : E513 - E520
  • [48] Utilization and relative value of breast cancer adjuvant chemotherapy regimens in the community
    Patt, D. A.
    Espirito, J. L.
    Turnwald, B.
    Hoverman, J. R.
    Neubauer, M. A.
    Cartwright, T. H.
    Brooks, B. D.
    Busby, L. T.
    Sitarik, M. A.
    Kolodziej, M. A.
    Ginsburg, A. L.
    Sheth, S.
    Garey, J. S.
    Clayton, M.
    Nelson, G. C.
    Anderson, R. W.
    Beveridge, R. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [49] Social and racial differences in selection of breast cancer adjuvant chemotherapy regimens
    Griggs, Jennifer J.
    Culakova, Eva
    Sorbero, Melony E. S.
    Poniewierski, Marek S.
    Wolff, Debra A.
    Crawford, Jeffrey
    Dale, David C.
    Lyman, Gary H.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18) : 2522 - 2527
  • [50] Metabolic study of women receiving adjuvant chemotherapy for breast cancer.
    Heimburger, DC
    Heini, AF
    Gower, BA
    Kim, R
    Ferguson, SM
    FASEB JOURNAL, 1998, 12 (04): : A567 - A567
12345